Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype - Wikidata - awgldk - TriplyDB

Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype

Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype

http://www.wikidata.org/entity/Q28298099

about

Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions The Diagnosis and Treatment of Autoimmune Encephalitis Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms Glutamatergic neuron-targeted loss of LGI1 epilepsy gene results in seizures Faciobrachio-crural dystonic seizures in LGI1 limbic encephalitis: A treatable cause of falls.Neuronal central nervous system syndromes probably mediated by autoantibodies Progress in autoimmune epileptic encephalitis Autoimmune encephalitis in psychiatric institutions: current perspectives Seizures and Epilepsies due to Channelopathies and Neurotransmitter Receptor Dysfunction: A Parallel between Genetic and Immune Aspects Neuroinflammation: Ways in Which the Immune System Affects the Brain Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies Autoimmune encephalopathies.Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures.Teaching Video NeuroImages: Faciobrachial dystonic seizures: Pathognomonic phenomenology.Striking basal ganglia imaging abnormalities in LGI1 ab faciobrachial dystonic seizures.Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography Emergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis.Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis Clinical features of limbic encephalitis with LGI1 antibody.Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis.Neuronal surface antibody-mediated autoimmune encephalitis.Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study A case of autoimmune epilepsy associated with anti-leucine-rich glioma inactivated subunit 1 antibodies manifesting electrical shock-like sensations and transparent sadness.Autoimmune Encephalitis: An Expanding Frontier of Neuroimmunology LGI1 antibody encephalopathy overlapping with sporadic Creutzfeldt-Jakob disease.Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.The Laboratory Diagnosis of Autoimmune Encephalitis Autoimmune epilepsies Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia.The recognition and treatment of autoimmune epilepsy in children.Differences in epileptic symptoms depending on the type of autoimmune-mediated limbic encephalitis.Immune therapy in autoimmune encephalitis: a systematic review.Antiepileptic drug therapy in patients with autoimmune epilepsy.Anti-leucine-rich glioma-inactivated 1 limbic encephalitis: A case report and literature review.Autoimmune encephalitis.Diagnostic and therapeutic strategies for management of autoimmune encephalopathies.

P2860

Q26741919-ADB14206-7D55-4D23-84ED-16B109ADF306 Q26769676-F49C782F-75C6-4CF9-A370-AC5499D1F102 Q26775915-840D9E73-BA33-4609-AB85-E83212DB4C7E Q26824216-87A02F2E-9F06-4AD3-8E2D-463C453B57F0 Q27006941-FD39C30D-8785-4DD7-B0ED-877CF9D3054C Q27303973-6E0B4839-77DA-4122-8023-6FAEECFC7EB0 Q27312216-98BD3746-A573-413F-9C1E-A680233D1E89 Q28072253-F1C1346C-BBEA-472B-9297-8437B883BBCF Q28077159-54F4205F-C73F-4B05-9295-74934855EA25 Q28079666-F2437AEF-2665-49DB-939D-05CB0E24D178 Q28079865-864ED672-51AE-4711-95BF-1F4E1F2E92F8 Q28080620-C32F38AD-C8AC-465F-934C-3D1A3DD88349 Q28084055-E0B37C0F-70F9-4F8A-A2A9-BC897E0528B0 Q30389491-A1C290C1-6208-4B47-860A-C9645C558479 Q30666620-4AEA5A29-9BDD-4DCC-ACD3-29A8D31584C2 Q30712035-DF918636-1F57-4CD7-BFC2-ACBD7BDD9B4A Q30841885-439D90B1-A4C0-4179-BDF8-503463B81E55 Q31167257-663A3395-CAC9-43FD-815D-8C3728F99D9F Q33552867-76790168-2029-4538-88C8-607F201258B6 Q33603847-42D847E5-79F2-43CA-B5C2-717D13FC5EFB Q33825874-AF7BC105-BDFE-464E-874A-2A13885A57B4 Q34490340-F2A060BE-6FC0-47E3-83CF-A342FF0B4735 Q35392781-882F7FB6-22FE-412F-9040-6248E68EB34D Q35760046-1A402EA1-32B4-4F65-958A-2C8470B20434 Q35771307-AFACE910-739D-4BC7-BBA1-C27420556816 Q35895181-ECE23F07-5423-4220-AF37-8DA29E86F6C0 Q36106308-FEEDF1BC-FF5D-4AAF-AD00-FD85D3945432 Q36856592-2E21A3F3-341A-4465-B1B6-F01FE6908143 Q37015406-40C56F25-A590-4AF6-9FAD-8695A48B7290 Q37116925-C8C7596A-1432-45CA-8C6A-4C3AEBB9B0F9 Q37548955-00A32D6E-72F6-4588-8DFA-8701242C0239 Q37717429-5BF178EA-79E8-4533-B64D-666B70F75327 Q38245624-272AD6DF-EB0C-422E-AB7F-01915D04259A Q38284599-F5F23C73-79B5-4A5D-94ED-9747908990AA Q38545106-BACD4C32-9526-4556-AEAC-0FB903DB3C04 Q38630867-0A9BAF8E-ACA8-45D0-8056-8E46B42009B4 Q38691931-9072C318-8782-4BDB-9FE7-1D50C8DC3C9B Q38738477-2C273418-D4C3-4AFF-9D8A-1BC9FFA1813C Q38743365-7A589951-D255-4977-B434-0079DAC67884 Q38832800-8B779100-FD71-4365-B10D-D1D10DBE4071

P2860

Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype

http://www.wikidata.org/entity/Q28298099

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@ast

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@en

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@nl

type

label

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@ast

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@en

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@nl

prefLabel

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@ast

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@en

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@nl

P1433

Q28298099-8C641097-C428-4351-AC6D-CAA8F2F50D85

P1476

Q28298099-DF5EA03B-4B83-4E6F-8700-32FD5BFC4B76

P2093

Q28298099-1535AB25-4D8D-4A0F-97E6-14A4796EDDDA

Q28298099-1BECDB6D-FB23-4C0E-9EE9-CCEAE23FE5DD

Q28298099-2DEF67F4-7EC7-458F-8E47-35F16C61AE3E

Q28298099-46D02ADE-F4B5-44DA-A374-6EF51AC43949

Q28298099-62ACCEF3-A3F4-48F1-B7ED-27A67EE3C72F

Q28298099-86AC5E92-8CAD-44A3-9DF2-0C5E29EB5D98

Q28298099-A216F7DD-1711-4F30-AE81-EF0DC3420F51

Q28298099-CA1A78E0-50EA-49A7-9648-108E490AEB42

Q28298099-CA471AEE-184D-4F2E-A25E-55D91A5318B4

Q28298099-DB7B6113-3DEB-4DC9-A268-ABD9071CEF31

P2860

Q28298099-00EC073E-C5F4-4953-81CE-F3043E5F688C

Q28298099-0E10CACB-97F5-436C-8009-C62759B4964D

Q28298099-205D4819-0E4B-4529-9225-622D5B308F71

Q28298099-25520F5C-483F-4A76-86A8-38264A6B6AFF

Q28298099-28DA2FD5-8472-4927-9926-B8F92F78A491

Q28298099-29370E8A-5BEB-4F0C-83F4-139C8FD0B3EF

Q28298099-2B5F29EE-0F44-4E99-A58C-0105B7132611

Q28298099-314B6D27-875A-4BAE-B713-B2BB8191E393

Q28298099-32FE19AD-A4A9-4BB6-B75C-BA57FF238B8F

Q28298099-330E378F-6370-4208-B603-C2A1F8902567

P304

Q28298099-B9F10D24-C5BD-4A50-BB01-AF70E1822111

P31

Q28298099-7BD310A0-870B-45F1-8F00-80A94CA0AD8F

P3181

Q28298099-9A0592E7-8159-4ACF-BC92-69690E498DDA

P356

Q28298099-DFCCF6C6-E575-4943-AF72-1DFD9F53AEAF

P407

Q28298099-7063C8F7-1973-4EB4-9643-34B4D575F0EF

P433

Q28298099-346C973B-DB16-466E-9C23-80E45B8075E3

P478

Q28298099-2B7CA20F-C31F-425F-81C4-1DC496E469F4

P50

Q28298099-1ECE5871-70A4-450C-A25E-A09C41DE1BCD

Q28298099-215B1152-5232-4368-B760-811B46091C9A

Q28298099-383520C9-87C6-4CC1-9A28-7683BCD05598

Q28298099-67C66879-D22C-4E14-8F1F-8854469256B6

Q28298099-9A517BCB-714A-47D2-B95D-5466506ED085

Q28298099-D917A407-6BC1-43B8-8E02-0C90F62173F1

P577

Q28298099-47C4D056-097A-4527-A128-3E372FEEB11B

P5875

Q28298099-4881A78E-4913-4F30-AA39-57C896E3A476

P698

Q28298099-42548685-2891-4B90-8FBC-C3C354F8FA72

P921

Q28298099-55DE6868-42E9-4CAC-9073-4774873DC0AD

P3181

P356

P1433

P1476

Faciobrachial dystonic seizure ...... ment in a broadening phenotype

@en

P2093

Bethan Lang

http://www.w3.org/2001/XMLSchema#string

Clive R Rosenthal

http://www.w3.org/2001/XMLSchema#string

Emily N Manning

http://www.w3.org/2001/XMLSchema#string

Jonathan M Schott

http://www.w3.org/2001/XMLSchema#string

Manuel J Cardoso

http://www.w3.org/2001/XMLSchema#string

Michael R Johnson

http://www.w3.org/2001/XMLSchema#string

Natalie L Voets

http://www.w3.org/2001/XMLSchema#string

Philippa Pettingill

http://www.w3.org/2001/XMLSchema#string

Rosemary Pettingill

http://www.w3.org/2001/XMLSchema#string

Shelagh J M Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Amnesia, cerebral atrophy, and autoimmunity

Potassium channel antibodies in two patients with reversible limbic encephalitis

Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

Clinical spectrum of voltage-gated potassium channel autoimmunity

Serial MRI of limbic encephalitis

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1

P304

3151-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

724866

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/BRAIN/AWT212

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 10

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

Charlotte J. Stagg

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256469392

http://www.w3.org/2001/XMLSchema#string

P698

24014519

http://www.w3.org/2001/XMLSchema#string

P921